Author:
Koo Chiew-Loon,Kok Lai-Fong,Lee Ming-Yung,Wu Tina S,Cheng Ya-Wen,Hsu Jeng-Dong,Ruan Alexandra,Chao Kuan-Chong,Han Chih-Ping
Abstract
Abstract
Background
Endocervical adenocarcinomas (ECAs) and endometrial adenocarcinomas (EMAs) are malignancies that affect uterus; however, their biological behaviors are quite different. This distinction has clinical significance, because the appropriate therapy may depend on the site of tumor origin. The purpose of this study is to evaluate 3 different scoring mechanisms of p16INK4a immunohistochemical (IHC) staining in distinguishing between primary ECAs and EMAs.
Methods
A tissue microarray (TMA) was constructed using formalin-fixed, paraffin-embedded tissue from hysterectomy specimens, including 14 ECAs and 24 EMAs. Tissue array sections were immunostained with a commercially available antibody of p16INK4a. Avidin-biotin complex (ABC) method was used for antigens visualization. The staining intensity and area extent of the IHC reactions was evaluated using the semi-quantitative scoring system. The 3 scoring methods were defined on the bases of the following: (1) independent cytoplasmic staining alone (Method C), (2) independent nucleic staining alone (Method N), and (3) mean of the sum of cytoplasmic score plus nucleic score (Method Mean of C plus N).
Results
Of the 3 scoring mechanisms for p16INK4a expression, Method N and Method Mean of C plus N showed significant (p-values < 0.05), but Method C showed non-significant (p = 0.245) frequency differences between ECAs and EMAs. In addition, Method Mean of C plus N had the highest overall accuracy rate (81.6%) for diagnostic distinction among these 3 scoring methods.
Conclusion
According to the data characteristics and test effectiveness in this study, Method N and Method Mean of C plus N can significantly signal to distinguish between ECAs and EMAs; while Method C cannot do. Method Mean of C plus N is the most promising and favorable means among the three scoring mechanisms.
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference40 articles.
1. Luran JR, Bidus MA, Elkas JC: Uterine cancer, cervical and vaginal cancer. Novak's Gynecology. Edited by: Berek RS. 2007, Lippincott Williams & Wilkins (LWW), Philadelphia, 1343-1402. 14
2. Schorge JO, Knowles LM, Lea JS: Adenocarcinoma of thecervix. Curr Treat Options Oncol. 2004, 5: 119-27. 10.1007/s11864-004-0044-0.
3. Wehling M: Translational medicine: science or wishful thinking?. J Transl Med. 2008, 6: 31-10.1186/1479-5876-6-31.
4. Zaino RJ: The fruits of our labors: Distinguishing endometrial from endocervical adenocarcinoma. Int J Gynecol Pathol. 2002, 24: 1-3. 10.1097/00004347-200201000-00001.
5. Lotze MT, Gray J: A Life in Passing: Jonathan Gray. J Transl Med. 2007, 5: 54-10.1186/1479-5876-5-54.
Cited by
90 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献